TrialSignal
Clinical trial intelligence report
Vitamin D Status and Metabolism in Pregnant and Nonpregnant Control Women Consuming Controlled and Equivalent Intakes of Vitamin D
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 25, 2026
Report code
NCT03051867-Jun 25, 2026
NCT ID
NCT03051867
Status
COMPLETED
Phase
Completed (Observational Study)
Sponsor
Cornell University
Executive brief
Investment-Ready Snapshot
This study, sponsored by Cornell University, investigates the impact of pregnancy on vitamin D metabolism and its implications for maternal and fetal bone health. Given the increasing awareness of the importance of vitamin D during pregnancy, the findings could inform dietary recommendations and supplementation guidelines, potentially leading to market opportunities in maternal health products. The competitive landscape includes nutritional supplements and pharmaceutical interventions targeting vitamin D deficiency in pregnant women. Companies focusing on maternal health and nutrition may find strategic partnerships or product development opportunities based on the outcomes of this study. Due diligence should consider the regulatory landscape surrounding dietary supplements and the potential for clinical guidelines to evolve based on emerging evidence.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT03051867
Indication
Pregnancy
Modality
RNA therapy
Target
Vitamin D metabolism pathways, specifically focusing on the role of the placenta in modulating vitamin D metabolites during pregnancy.
Intervention
Not reported
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.